Archives

Addionics (a global leader in battery technology) announced a Series B funding round of $39 million. This funding round was co-led by GM Ventures and Deep Insight, with participation from Scania, along with new and returning strategic investors. And the funds will be used to bolster the company's manufacturing capabilities and advance global business engagements.

Kingswood Capital Management, an LA-based private equity firm focused on buyouts of middle-market businesses with operational improvement potential, announced the final closing of Kingswood Capital Opportunities Fund III, L.P., with total capital commitments of $1.5 billion, including a 5% GP commitment, emphasizing the firm’s confidence in its strategy and providing strong alignment with its investors. This brings the firm’s total assets under management (AUM) to about $3.2 billion.

After.com, a platform that helps families navigate end-of-life services without ever needing to step foot inside a funeral home, announced it has raised $10 million for its Series A funding round led by HIPstr (the early-stage investment arm of HighPost Capital). After.com plans to use the proceeds to enter new markets, add talent throughout the organization, and further enhance its marketing efforts to support both the pre-need and at-need business segments.

Cowbell, a leading cyber insurance provider for small and medium-sized enterprises (SMEs), announced that it has closed a $60 million Series C equity investment from Zurich Insurance Group.

Thesis, which is one of the longest-standing venture studios funding and building brands on Bitcoin, announced a strategic funding round led by Ledger Cathay Fund (Ledger and Cathay Innovation's early-stage venture fund) for Mezo, its permissionless Bitcoin Economic Layer. With this $7.5 million round, this brings the total funding for Mezo to $30 million following its launch earlier this year. The other investors in the strategic round include ArkStream, Aquarius Fund, Flowdesk, GSR, Origin Protocol, and Bybit ecosystem project, Mantle's EcoFund.

Allium, a leading blockchain data platform for enterprises, announced that it raised a $16.5 million Series A funding round led by Theory Ventures with participation from seed investors Kleiner Perkins and Amplify Partners. Tomasz Tunguz, Founder of Theory Ventures, will join the board as part of its investment. This brings the total funding raised to $21.5 million.

Lynch Regenerative Medicine (LRM) announced it has completed a Series A funding round to develop and commercialize innovative skin rejuvenation and regeneration solutions based on the only tissue growth factor approved by the FDA and other international regulator bodies to be safe and effective in human tissue regeneration and wound healing: pure platelet-derived growth factor (PDGF).

Novocuff - a medical device company dedicated to improving pregnancy outcomes and reducing the risk of preterm birth - announced it has successfully closed an oversubscribed $26 million Series A funding round after raising an initial $2 million seed round. AXA IM Alts, through its Global Healthcare Private Equity Strategy, led the round with a $14 million investment, along with significant participation from Laerdal Million Lives Fund, and continued support from existing investors and new investors Laborie, RH Capital, Avestria Ventures and March of Dimes.

GovPort Technologies announced an investment of $2.8 million from PruVen Capital and Fin Capital. GovPort essentially helps prime federal contractors (primes) reduce administrative costs and risk by automating compliance tasks and creating a digital and auditable trail of their subcontractors’ compliance.

Slope announced it has closed $65 million in a new round of funding, bringing the total funding to $252 million ($77 million in equity and $175 million in debt). This funding round will be used for scaling operations as the B2B payments platform continues serving many of the world’s largest enterprises. Along with J.P. Morgan Payments, other participants in the round include Y Combinator, Jack Altman, and Max Altman’s new fund Saga.

Autobahn Therapeutics (a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders) announced the closing of an oversubscribed $100 million Series C funding led by Newpath Partners, with participation from new investors Canaan Partners, Monograph Capital, and Insight Partners. All of the company’s existing investors participated in the round, including founding investors ARCH Venture Partners and Blue Owl Healthcare Opportunities, BVF Partners, Invus, Samsara BioCapital, Biogen, Bristol Myers Squibb, Pfizer Ventures, Section 32, Alexandria Venture Investments and GT Healthcare Capital Partners.

Oisín Biotechnologies (a privately held biotechnology company focused on mitigating the effects of age-related diseases) announced the first closing in a $15 million Series A funding round. AbbVie Ventures led the first close. And in connection with the funding, they will join the Oisín Board of Directors and Scientific Advisory Board.

SoundHealth (a medical technology company harnessing the power of AI and medical science to improve patient outcomes) has introduced SONU. SONU is the world’s first FDA De Novo authorized, AI-enabled, and wearable medical device for treating moderate to severe nasal congestion due to allergic and non-allergic rhinitis for at-home use by individuals 22 years of age and older.

Kestra Medical Technologies (a privately held wearable medical device and digital healthcare company) announced an oversubscribed $196 million funding round to support the expansion of their commercial organization and advance its goals of protecting at-risk patients with its modern Wearable Cardioverter Defibrillator (WCD).

Leading trust management platform Vanta announced that it has raised a $150 million Series C funding round at a valuation of $2.45 billion. The funding round was led by Sequoia Capital along with new investors Growth Equity at Goldman Sachs Alternatives, J.P. Morgan and existing investors Atlassian Ventures, Craft Ventures, CrowdStrike Ventures, HubSpot Ventures, Workday Ventures and Y Combinator. The most recent funding round brings Vanta’s total funds raised to $353 million since 2021.

Pearl, a global leader in dental AI, announced that it has raised $58 million in Series B funding to accelerate its mission to elevate patient care in dentistry. Left Lane Capital led the funding round, with participation from Smash Capital, Alpha Partners, and existing investors, Craft Ventures and Neotribe Ventures. This funding round marks the highest investment ever in dental artificial intelligence.

Clarapath, a medical robotics company modernizing and transforming how pathology laboratories process tissue, announced it raised $36 million in Series B-1 funding round led by Northwell Ventures. And additional new strategic investors participated in the funding round, including CU Healthcare Innovation Fund, Mayo Clinic, and Ochsner Ventures, bringing the company's total funding to $75 million.

Scorpion Therapeutics, a clinical-stage oncology company dedicated to transforming the lives of cancer patients by redefining the frontier of precision oncology, announced the closing of a $150 million Series C financing. The funding was co-led by Frazier Life Sciences and Lightspeed Venture Partners and included additional new support from Willett Advisors and leading healthcare institutional investors, along with existing investors Omega Funds, Vida Ventures, Atlas Venture, Abingworth, Fidelity Management & Research Company, Boxer Capital, EcoR1 Capital, LLC, Surveyor Capital (a Citadel company), Invus, Wellington Management, Nextech Invest Ltd. (on behalf of one or more funds managed by it), OrbiMed, Logos Capital, Woodline Partners LP, and Casdin Capital.

Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, announced it has raised an oversubscribed $5.2 million seed round led by The Engine Ventures. And additional participating investors include Illumina Ventures, Time Boost Capital, the American Cancer Society Bright Edge and the Oetgen family.

ACEL Power, an innovator in marine electric innovation, announced it has closed its oversubscribed Series A round with $10 million in funding. The funding was led by Tau Capital, which is an Abu Dhabi-based private venture capital firm committed to supporting advancements in science and technology for a positive impact on the world.

Cart.com - a leading provider of unified commerce and logistics solutions that enable merchants to sell and fulfill wherever their customers are - announced it has secured a $105 million term loan facility provided by funds and accounts managed by BlackRock. The latest facility helps consolidate Cart.com’s venture debt at competitive terms as the company continues its rapid growth trajectory.

AI due diligence provider Xapien announced the completion of its £8 million ($10 million) Series A funding round, led by YFM Equity Partners. This brings the total funding to £14 million ($17.8 million).

Heimdall Power, a company that is driving power grid optimization for utility companies around the world, announced the closing of its $25 million Series B funding round. This funding round was co-led by international energy giant Orlen, Nordic cleantech fund NRP Zero and the Steinsvik Family Office. And additional investments were made by existing investors, Investinor, Eviny, Hafslund, Lyse, and Sarsia Seed.

Vectara, a trusted Generative AI (GenAI) product platform, announced it has closed a $25 million Series A round led by FPV Ventures and Race Capital. The additional investors include Alumni Ventures, WVV Capital, Samsung Next, Fusion Fund, Green Sands Equity, and Mack Ventures.

CatalYm announced the completion of a $150 million Series D financing. The oversubscribed funding round was led by new investors, Canaan Partners and Bioqube Ventures, and joined by Forbion's Growth Opportunities Fund, Omega Funds and Gilde Healthcare. Existing investors Jeito Capital, Brandon Capital Partners, Novartis Venture Fund and Vesalius Biocapital III also participated in the round.

Seven Starling, a virtual provider of women's behavioral health services, announced it has raised $10.9 million in Series A funding. RH Capital led the oversubscribed investment round, with participation from insiders Pear VC, Expa, Magnify Ventures, Emerson Collective, and Inflect Health, and new investors including Zeal Capital Partners, Ulu Ventures, Fiore Ventures, the March of Dimes, Rogue Venture Partners, Graham & Walker, and Wisdom Ventures.